Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hidekazu Yamaura
Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK Among Treatment-Naïve Patients With Advanced Lung Adenocarcinoma
PLoS ONE
Multidisciplinary
Related publications
PCR-based Detection of EGFR, ALK, KRAS and BRAF Mutations in Russian Patients With Lung Adenocarcinoma: A Single-Center Experience
Neoplasma
Cancer Research
Fusion of EML4 and ALK Is Associated With Development of Lung Adenocarcinomas Lacking EGFR and KRAS Mutations and Is Correlated With ALK Expression
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Preoperative Serum Carcinoembryonic Antigen Levels Are Associated With Histologic Subtype, EGFR Mutations, and ALK Fusion in Patients With Completely Resected Lung Adenocarcinoma
OncoTargets and Therapy
Oncology
Pharmacology
PIK3CA Mutations Frequently Coexist With EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup
PLoS ONE
Multidisciplinary
Combination of Chemotherapy and Gefitinib as First-Line Treatment for Patients With Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: A Randomized Controlled Trial
International Journal of Cancer
Cancer Research
Oncology
Relationship Between EGFR Mutation and Computed Tomography Characteristics of the Lung in Patients With Lung Adenocarcinoma
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
Chemotherapy Combined With Bevacizumab for the Treatment of Advanced Lung Adenocarcinoma Cancer Harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 Mutations: A Case Report
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
EGFR Inhibitors in Treatment of Lung Adenocarcinoma
Research in Oncology
